Company

Bioventix (LSE:BVXP)

Bioventix develops high-affinity sheep monoclonal antibodies for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.

About BVXP

Related Articles

Compass pointing towards 'best price'
Investing Articles

2 of the best AIM stocks to buy now

On the hunt for the best AIM stocks to buy, Paul Summers is bullish on these two out-of-favour companies

Read more »

Investing Articles

Top British small-cap stocks for January 2022

We asked our freelance writers to share their best British small-cap stocks for January, including Bioventix and Calnex Solutions.

Read more »

Investing Articles

1 secret UK growth stock I’d buy now!

One of this Fool's watchlist stocks has fallen heavily in 2021. He thinks now might be a perfect time to…

Read more »

Investing Articles

Top British small-cap stock for November

We asked our freelance writers to share their best British small-cap stocks for November, including Trifast and Card Factory.

Read more »

Investing Articles

Top small-cap stocks for July

Bioventix (LSE:BVXP) Bioventix develops high-affinity sheep monoclonal antibodies for use in immunodiagnostics focusing on the areas of clinical diagnostics and…

Read more »

A colourful firework display
Investing Articles

I’d buy these 2 growth stocks for explosive returns!

Looking for top UK shares to buy now? These two biotech growth stocks have been generating explosive returns for many…

Read more »

Syringe and vial on blue background
Investing Articles

Looking for shares to buy now? 1 biotech stock I’d buy today

Looking for shares to buy now? Zaven Boyrazian analyses a biotech firm that is vital to the development of new…

Read more »

Investing Articles

Look to the future! I’d buy these AIM stocks today

AIM stocks are often risky investments, but they can also see tremendous gains. One Fool looks at his top picks…

Read more »

Investing Articles

What market crash? These 3 growth stocks have bounced back hard

Paul Summers highlights three growth stocks that have rebounded strongly from March's market turmoil.

Read more »

Investing Articles

Can you afford to overlook this solid-looking growth and dividend stock?

This share is on my radar, and I’m poised to pounce!

Read more »